Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of Lorigerlimab in Participants With Advanced Solid TumorsFemale Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, cervical clear cell adenocarcinoma, endometrium neoplasm, fallopian tube clear cell adenocarcinoma, female reproductive system disorder, female reproductive system neoplasm, neoplasm, ovarian clear cell adenocarcinoma, uterine disorderRecruitingPhase 22026-06-02NCT06730347

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
MacroGenics12

16 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Gangnam Severance HospitalSeoulSouth Korea39
Korea University Guro HospitalSeoulSouth Korea83
McGill UniversityMontrealCanada2
National Cancer CenterGoyang-siSouth Korea1
Ochsner MD Anderson Cancer CenterNew OrleansUnited States1
Princess Margaret Cancer CenterTorontoCanada30
Samsung Medical CenterSeoulSouth Korea21
Seoul National University HospitalSeoulSouth Korea1
Seoul National University Hospital Bundang HospitalSeongnam-siSouth Korea1
START MidwestGrand RapidsUnited States79
START San AntonioSan AntonioUnited States30
The University of Texas MD Anderson Cancer Center, Gynecologic Oncology CenterHoustonUnited States1
UCLALos AngelesUnited States80
West Penn Allegheny HealthPittsburghUnited States2
Wisconsin Institute Medical Research- UW Cancer ConnectMadisonUnited States1
Yonsei University Health System Severance HospitalSeoulSouth Korea2